These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7954036)

  • 21. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular effects of ACE inhibition by perindopril.
    Michel JB; Levy BI
    Drugs; 1990; 39 Suppl 1():39-42. PubMed ID: 2407491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
    Bennett MA; Thurston H
    Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension.
    Baumbach GL; Chillon JM
    J Hypertens Suppl; 2000 May; 18(1):S7-11. PubMed ID: 10939784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
    Moreau P; Takase H; Küng CF; Lüscher TF
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
    Asmar RG; Pannier BM; London GM; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S37-9. PubMed ID: 1725199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perindopril treatment in the prevention of stroke in experimental animals.
    Lee RM; Wang H; Smeda JS
    J Hypertens Suppl; 1996 Dec; 14(6):S29-33. PubMed ID: 9023713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remodelling of the vascular system in response to hypertension and drug therapy.
    Levy BI; Safar ME
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():33-7. PubMed ID: 1395115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of perindopril on the renal haemodynamic changes associated with adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Mimran A
    J Hypertens Suppl; 1988 Dec; 6(3):S75-7. PubMed ID: 2852238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects of perindopril].
    Benetos A; Levy B; Asmar R; Safar M
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):483-6. PubMed ID: 2589812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [International experts commented on the characteristics of perindopril, a new highly potent and well tolerated ACE. Perindopril has been able to reduce the thickness and rigidity of the arterial wall in animal studies].
    Med Clin (Barc); 1991 May; 96(19):suppl 2 p.. PubMed ID: 1875747
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-dependent effects of perindopril on blood pressure and small-artery structure.
    Thybo NK; Korsgaard N; Eriksen S; Christensen KL; Mulvany MJ
    Hypertension; 1994 May; 23(5):659-66. PubMed ID: 8175177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure.
    Mulder P; Devaux B; el Fertak L; Compagnon P; Richard V; Henry JP; Scalbert E; Desché P; Macé B; Thuillez C
    Am J Cardiol; 1995 Nov; 76(15):28E-33E. PubMed ID: 7484884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
    Chrysant SG
    Am Heart J; 1998 Feb; 135(2 Pt 2):S21-30. PubMed ID: 9488609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral vasculature in essential hypertension.
    Mulvany MJ
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S6-10. PubMed ID: 8886506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.